CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-07-11). The draft was written by AI, the existence of all 3 cited sources was verified at the original page, and the verdict passed blind grading and adversarial audit. Methodology v0.6.
Verdict No. 333 · Search date 2026-07-11 · Methodology v0.6

Yohimbe bark extract,
does it really help with Improved erectile function and libido?

30-Second Summary
?
Evidence Grade ? · Safety caution
Erectile-function data for quantified yohimbine do not transfer directly to inconsistently dosed yohimbe bark products or establish improved libido
What the
research shows
Direct efficacy literature for erectile function concerns quantified yohimbine or yohimbine hydrochloride monotherapy, not yohimbe bark extract. The odds ratio of 3.85 from a seven-trial meta-analysis cannot be transferred to bark supplements, and no direct clinical trial of bark extract for erectile function or libido was identified. Yohimbine content across 49 supplements ranged from 0 to 12.1 mg, with only two products labeled accurately, so the verdict is deferred.
What the
ads claim
Product descriptions may connect drug trials of yohimbine to broad improvements in erection, libido, and male vitality from natural bark extract. Actual products can differ greatly in yohimbine per dose and other alkaloids and may not match trial dosing.
*

Useful facts when choosing a product

  • Yohimbe bark extract is a botanical material containing multiple alkaloids and is not the same formulation as quantified yohimbine hydrochloride.
  • An analysis of 49 U.S. supplements found 0 to 12.1 mg of yohimbine per serving, with accurate labels on only two products.
  • Clinical yohimbine doses were often in the range of 15-36 mg/day and may not map directly to marketed labels.
  • Sympathomimetic effects can include increased blood pressure and heart rate, anxiety, headache, gastrointestinal symptoms, and drug interactions.
Gap Measurement · Verdict 333 · ?
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

The 1998 meta-analysis by Ernst and Pittler pooled seven placebo-controlled trials of quantified yohimbine monotherapy and reported an odds ratio of 3.85 for erectile response. These were studies of the pharmaceutical compound yohimbine or yohimbine hydrochloride, not direct clinical trials of yohimbe bark extract for erectile function or libido. Drug evidence for yohimbine therefore cannot be transferred to bark supplements. Cohen and colleagues analyzed 49 supplements in 2016 and found 0 to 12.1 mg of yohimbine per recommended serving, with only two products labeled accurately. No direct clinical trial of bark extract alone for erectile function or libido was identified.

02

Why this is classified as ?

The direct human efficacy literature concerns quantified pharmaceutical yohimbine monotherapy, while the target yohimbe bark extract has no trial for erectile function or libido. Large content variation and inaccurate labeling across 49 supplements compound the ingredient and formulation mismatch, so the verdict is deferred with a question mark and no score.

Counterpoint. A pharmacologic signal for erectile function remains when yohimbine content is measured and standardized. This assessment does not extend that possibility to generic yohimbe supplements or to libido improvement as a whole.

Rejudgment record. Reassessment (cross-check reflected) — Direct efficacy literature concerns quantified pharmaceutical yohimbine monotherapy, while no direct clinical trial of yohimbe bark extract for erectile function or libido exists and supplement content varies from 0 to 12.1 mg, requiring deferral

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Ernst E, Pittler MH 1998Systematic review and meta-analysis of randomized placebo-controlled trials419Independent academic researchErectile response and adverse eventsQuantified yohimbine monotherapy was more likely than placebo to improve erectile response (OR 3.85); these were not bark-extract trials.Indirect key evidence
Wibowo DNSA et al. 2021Systematic review and meta-analysis8Academic institutions; no external funding reportedErectile function and sexual functionThe odds ratio for erectile-function improvement with yohimbine alone was 2.08, while overall sexual function was not significant with monotherapy.Indirect key evidence
Cohen PA et al. 2016Commercial-supplement composition analysis49Public and academic researchMeasured yohimbine content, label accuracy, and risk informationContent ranged from 0 to 12.1 mg per serving, and only 2 of 49 products were labeled accurately.Product reproducibility
§

Receipt — 3 References

All 3 cited sources were verified for existence at the original page (as of 2026-07-11).

Ernst E, Pittler MH. 1998. Yohimbine for erectile dysfunction: a systematic review and meta-analysis of randomized clinical trials. J Urol. 159(2):433-436. PMID: 9649257. DOI: 10.1016/S0022-5347(01)63942-9.
checked
Wibowo DNSA, Soebadi DM, Soebadi MA. 2021. Yohimbine as a treatment for erectile dysfunction: A systematic review and meta-analysis. Turk J Urol. 47(6):482-488. PMID: 35118966. DOI: 10.5152/tud.2021.21206.
checked
Cohen PA, Wang YH, Maller G, DeSouza R, Khan IA. 2016. Pharmaceutical quantities of yohimbine found in dietary supplements in the USA. Drug Test Anal. 8(3-4):357-369. PMID: 26391406. DOI: 10.1002/dta.1849.
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-07-11 · Corrections: none

Cite this verdict

Yohimbe bark extract (Pausinystalia johimbe) × Improved erectile function and libido Evidence Grade ? card
[Chamgap] Yohimbe bark extract (Pausinystalia johimbe) × Improved erectile function and libido — Evidence Grade ?. 3 cited sources checked. Source: https://health-receipt.pages.dev/en/verdicts/mens/yohimbe-bark-erectile-function-libido/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.